伴肝门淋巴结转移乙肝相关性肝细胞癌患者不同疗法生存差异分析

A Comparison of Overall Survival Difference of Different Treatment on Hepatitis B Virus-Related Hepatocellular Carcinoma with Perihilar Lymph Node Metastases

目的:分析乙肝相关肝癌伴肝门淋巴结患者行肝癌切除+肝门淋巴结清扫、动脉化疗栓塞术(TAE)及未行治疗患者生存率的差异。方法:乙肝相关肝癌伴肝门淋巴结转移患者32例,其中17例患者行肝癌切除+肝门淋巴结清扫,5例患者行TAE治疗,而有10例患者未行治疗,比较3组患者生存率。结果:肝癌切除+肝门淋巴结清扫患者及TAE患者生存率优于未行治疗组患者(P<0.05),而肝癌切除+肝门淋巴结清扫患者与TAE患者生存率比较,差异无统计学意义(P>0.05)。结论:肝癌切除+肝门淋巴结清扫术与TAE术均能延长患者生存期。

Objective： To investigate the overall survival rate difference among radical resection,TAE and without any treatment on hepatitis B virus-related hepatocellular carcinoma with perihilar lymph node metastases. Methods： 32 patients with HBV-related HCC with perihilar lymph node metastases,17 were performed radical resection,5 were performed TAE and no treatment was given to 10 of them. Overall survival（ OS） rates were analyzed in all groups. Results： The OS in both radical resection and TAE groups were better than no treatment group respectively（ P〈0. 05）,and there was no significant difference of OS between radical group and TAE group. Conclusions： TAE and radical resection could both prolong patients overall survival.